Table 5.
Influence of Receptor Conversion on Overall Survival, Disease-Free Survival, Post-Recurrence Survival
| OS Median | DFS Median | PRS Median | ||
|---|---|---|---|---|
| ER | +to- | 50(24.72–75.28) | 40(3.44–76.57) | 44(26.11–61.89) |
| -to+ | 56(40.50–71.50) | 58(10.53–105.47) | 43(20.63–65.37) | |
| - | 39(31.45–46.55) | 29(26.17–31.83) | 30(23.43–36.57) | |
| + | 60(54.51–65.49) | 72(50.24–93.76) | 56(50.96–61.04) | |
| PR | +to- | 56(48.27–63.73) | 56(20.55–91.45) | 54(39.77–68.23) |
| -to+ | 39(29.20–48.80) | 27(0.00–72.56) | 28(18.02–37.98) | |
| - | 44(33.69–54.31) | 29(25.72–32.28) | 31(16.45–45.55) | |
| + | 77(49.39–104.60) | 73(54.09–91.90) | 57(43.79–70.21) | |
| HER2 | +to- | 62(36.34–87.66) | 34(18.14–49.86) | 40(28.56–51.44) |
| -to+ | 33(12.60–53.40) | 95(53.37–90.89) | 92(52.34–87.88) | |
| - | 56(48.52–63.48) | 55(41.66–68.34) | 38(25.04–50.96) | |
| + | 43(24.21–61.79) | 54(21.56–86.44) | 55(28.16–81.84) |